Search Results

South Korea's Medical Radiation Examinations Exceed 430 Million Annually, with CT Scans Accounting for 67.1% of Radiation Dose

According to the "2025 National Medical Radiation Assessment Yearbook" released by the Korea Disease Control and Prevention Agency on August 28, South Koreans underwent a total of 431.59 million medical radiation examinations last year, averaging 8.4 examinations per person. Over the past five years, the number of medical radiation examinations in South Korea has continued to rise, with last year's figure increasing by 4.6% year-on-year and 29.6% compared to 2021. The report shows that the collective radiation dose from medical radiation examinations in South Korea increased from 136,804.73 person-sieverts in 2021 to 167,659.18 person-sieverts last year, an increase of 22.6%. On a per capita basis, the radiation dose rose from 2.64 millisieverts to 3.24 millisieverts. The Korea Disease Control and Prevention Agency stated that with advances in medical technology, an aging population, and growing demand for health checkups, the use of medical radiation examinations in public healthcare services continues to expand.

2026-08-28

Bruce Power Aims to Generate Over CAD 13.3 Billion in Economic Impact in Canada Over Next 18 Months

Bruce Power recently stated that over the next 18 months, the company expects to generate more than CAD 13.3 billion in economic impact across Canada, with related investments primarily stemming from its nuclear plant operations and life extension programs, supporting businesses and jobs in Ontario and other regions of Canada. Bruce Power stated that since launching the "Canada First" program in 2025, the company has invested over CAD 6.6 billion in Canada between January 2025 and June 2026, and plans to invest an additional CAD 7.7 billion by the end of 2027. The company noted that its spending within Canada accounts for more than 95% of total expenditures. As a nuclear operator located in Bruce County, Ontario...

2026-08-28

South Korea's Daewoong Pharmaceutical Partners with Promedius to Promote AI Osteoporosis Screening Solution Using Chest X-rays

Daewoong Pharmaceutical announced on August 27 that it has signed a sales, distribution, and joint promotion agreement with Promedius, a medical imaging AI company, to promote Osteo Signal, an AI-based osteoporosis risk screening solution using chest X-rays, in South Korea. This partnership also marks Daewoong Pharmaceutical's expansion from its existing osteoporosis treatment business into the AI-assisted diagnostics field. Under the agreement, Daewoong Pharmaceutical will leverage its business network covering medical institutions across South Korea, along with its sales and marketing capabilities, to bring the solution into more clinical settings. Promedius will provide medical imaging AI technical support to assist in its deployment in real-world medical environments.

2026-08-27

Hyogo Medical University Hospital to Launch Japan's First Elekta Evo Linear Accelerator System Treatments

Elekta K.K. announced on August 27 that its high-precision radiation therapy device, the Elekta Evo linear accelerator system, will be installed for the first time in Japan at Hyogo Medical University Hospital, with the first treatment scheduled to commence on September 24, 2026. This marks the entry of this next-generation radiation therapy system into clinical application in Japan. As the number of cancer patients increases, the demand for personalized and precise treatment in the field of radiation therapy continues to rise. The Elekta Evo is positioned as a next-generation radiation therapy system capable of covering both routine and more complex cancer treatment scenarios. The system is equipped with Iris, an AI-driven high-definition imaging technology, which enables clearer visualization of the positional relationships between organs in the patient's body...

2026-08-27

Department of Nuclear Medicine at the Affiliated Hospital of Southwest Medical University Completes Its First PET/CT-Guided Interventional Puncture Procedure

From August 21 to 22, Professor Sun Long from the PET Center of the First Affiliated Hospital of Xiamen University was invited to the Department of Nuclear Medicine at the Affiliated Hospital of Southwest Medical University for academic exchange, and on the following day provided on-site guidance for the hospital's first PET/CT-guided interventional puncture procedure. The successful completion of this procedure marks a new clinical practice milestone for the department in the field of interventional nuclear medicine. On August 21, Professor Sun Long delivered a special lecture titled "Exploration of Clinical Integrated Application of Diagnostic Nuclear Medicine and Interventional Nuclear Medicine Based on the PET Platform," focusing on how the PET platform extends from disease diagnosis and precise localization to interventional diagnosis and treatment. Drawing on clinical practice and typical cases, he introduced the application of interventional nuclear medicine in lesion...

2026-08-27

Lanzhou Taiji Completes Key Commissioning of First Domestic Multi-Ion Therapy Device HiTS400

The first domestically produced multi-ion therapy device HiTS400, independently developed by Lanzhou Taiji and installed at Shandong Cancer Hospital, recently completed phased joint commissioning. After one week of operational testing, all beam parameters of the device met or exceeded contractual requirements, laying the foundation for subsequent clinical registration work. According to reports, HiTS400 is a medical ion accelerator independently developed by Lanzhou Taiji with full intellectual property rights. It can stably deliver four ion species: C^6+, H^+, He^2+, and O^8+, and is equipped with multi-angle fixed treatment nozzles and a lightweight superconducting heavy-ion rotating gantry, integrating modulated scanning technology to advance the development and application of multi-ion combined therapy devices. On August 14, 2026, the device obtained an amendment to its Radiation Safety License from the Ministry of Ecology and Environment, granting qualification for commissioning and operation. In the early morning of August 20, the equipment achieved stable acceleration and precise extraction of carbon ion beams. Measured data show that the particle number after synchrotron acceleration reached 3.26E9 ppp, the terminal particle number reached 3.02E9 ppp, the extraction efficiency was 92%, and beam stability was no less than 95%.

2026-08-26

New Analytical Laboratory Completed at Oak Ridge to Support U-233 Cleanup and Medical Isotope Supply

The U.S. Department of Energy Oak Ridge Environmental Management Office (OREM) and its contractor Isotek Systems completed installation of a new analytical laboratory at Oak Ridge National Laboratory (ORNL) on August 25, 2026. The laboratory will support ORNL's highest-priority environmental cleanup project and accelerate delivery of critical medical isotope materials for cancer treatment research. Isotek Systems is responsible for removing the U.S. uranium-233 inventory stored at Oak Ridge National Laboratory. Uranium-233 was primarily developed in the 1950s and 1960s, initially intended for use as nuclear reactor fuel, but was later proven unsuitable as a commercial fuel source...

2026-08-26

Fujifilm Launches New X-ray Bone Densitometer for Early Osteoporosis Screening

Fujifilm Corporation announced on August 26 that it has begun selling a new X-ray bone densitometry device designed to measure bone density in areas such as the lumbar spine and femur, supporting early detection of osteoporosis and fracture risk assessment. According to the company, the X-ray bone densitometer measures bone density using X-rays and is an important diagnostic tool for osteoporosis. The newly launched model is Fujifilm's first new device of this kind since 2018 and will be sold through its subsidiary Fujifilm Medical, with a price of approximately 20 million yen, varying depending on system configuration. The new device incorporates artificial intelligence technology, enhancing automated analysis functions. In the analysis of scanned images...

2026-08-26

Korea's Gil Medical Center Expands Application of Markerless Surface-Guided Radiation Therapy

Gachon University Gil Medical Center in South Korea announced on August 26 that it is expanding the clinical application of markerless surface-guided radiation therapy (SGRT) to enhance the precision and comfort of radiation therapy for cancer patients. According to the hospital, the proportion of markerless SGRT in its radiation therapy procedures has increased from 28% in the first half of 2025 to 37% in the first half of 2026. This change indicates that this treatment-assistive technology, which reduces the burden of skin marking on patients, is gaining broader clinical adoption. Markerless SGRT is an advanced technique used for patient positioning and monitoring during radiation therapy. Unlike conventional methods, patients do not need to retain target line markings on their skin; the treatment system can assist in confirming patient positioning through surface guidance, enabling radiation to be delivered more accurately to the target area.

2026-08-26

South Korea's SEC Joins National R&D Project for Active Dose Distribution Control Radiotherapy Equipment

South Korean electron beam source technology company SEC announced on August 25 that it has been selected as a joint research institution for the world's best active dose distribution control radiotherapy machine R&D project, and will participate in the development of core technologies related to next-generation radiotherapy equipment. The project is a newly established task under the Global Flagship Medical Device R&D Program of the South Korean government's medical device R&D fund, with a duration of 6 years and 6 months, starting from July this year and planned to continue until December 2032. The total project budget is 35.2 billion KRW, of which 28 billion KRW is government funding. Radexel serves as the lead institution, with SEC participating as a joint research institution. Other participating organizations include the Korea Atomic Energy Research Institute, Korea Testing Laboratory...

2026-08-25

Angolan Public Health and Medical Training Delegation Visits the Affiliated Hospital of Southwest Medical University, Focusing on Nuclear Medicine Diagnosis and Treatment Technologies

Recently, the "Angola Public Health and Medical Training Program," organized by the International Exchange Center of the Sichuan Provincial Health Commission, was held at the Affiliated Hospital of Southwest Medical University. An 18-member delegation comprising Angolan health administrators and medical personnel visited the hospital for exchange, with a focus on learning about the development and clinical application of nuclear medicine, urology, and other related disciplines. Jiang Yong, member of the Standing Committee of the Party Committee, Vice President of Southwest Medical University, and President of the Affiliated Hospital, welcomed the Angolan delegation and introduced the hospital's basic information. He stated that under the guidance of the Sichuan Provincial Health Commission, the hospital will leverage its disciplinary advantages as a university-affiliated hospital and a Sichuan Provincial Medical Center to carry out practical cooperation with Angola in talent cultivation, technical exchange, and hospital management.

2026-08-25

Iran Says Its Atomic Energy Organization's Medical Products Serve Over 1.5 Million Patients Annually

Mohammad Eslami, head of the Atomic Energy Organization of Iran, recently stated that more than 1.5 million patients in Iran use diagnostic and therapeutic products developed by the organization each year, and related medical products have also been exported to multiple countries. Eslami made these remarks at a ceremony held by Iran's nuclear industry to celebrate Physicians' Day. He said that promoting the application of advanced treatment methods is one of the key directions of Iran's scientific and technological development. The progress made by Iranian researchers in cold plasma technology has opened up a "brand-new and promising path" for medical applications. He stated that plasma technology has not only achieved notable results in the research field but has also played a role in healthcare settings.

2026-08-24

Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project Officially Launched

On August 22, the groundbreaking ceremony for the Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project was held in Hengyang, Hunan Province. Officials from Hengyang City and Zhuhui District, representatives from relevant colleges of the University of South China, investment institutions, and relevant personnel from New Radiopharmaceutical Medical attended the event. Cai Jiming, Chairman and President of New Radiopharmaceutical Medical, stated at the ceremony that the project's landing in Hengyang represents an important strategic layout for the company's nuclear medicine business. From contract signing to construction commencement, the project has received support from local governments, partners, and relevant organizations. The company will leverage this project as an opportunity to continue advancing the transformation of innovative achievements in the fields of medical isotopes and radiopharmaceuticals. Wang Jing, Deputy Mayor of Hengyang City, stated that Hengyang...

2026-08-22

CNNC Particle and Beijing Institute of Medical Device Testing Carry Out Joint Learning and Co-building Activity

On August 20, CNNC Particle and the Beijing Institute of Medical Device Testing carried out a joint learning and co-building activity. Representatives from both sides engaged in in-depth discussions on topics such as Party building leading business development, joint development of technical standards, and enhancement of inspection and testing capabilities. Wu Wei, Secretary of the Party Branch and Director of CNNC Particle, Wu Kechun, Deputy Secretary of the Party Committee of the Institute, and more than twenty Party member representatives from both sides participated in the event. At the beginning of the event, the CNNC Particle delegation visited the Institute's laboratories to gain first-hand understanding of its technical capabilities and research progress in inspection and testing. The Institute's advanced experimental platforms and technologies left a deep impression on the visitors. During the discussion session, Wu Kechun and Wu Wei delivered speeches respectively. Both sides...

2026-08-22

South Korea's Asan Medical Center Develops AI-Based Radiopharmaceutical Therapy Platform with U.S. Institutions

The research team at Asan Medical Center in Seoul announced on the 21st that it has recently been selected for the "2026 Korea-U.S. Innovative Outcomes R&D New Support Project" organized by the Ministry of Health and Welfare, and will collaborate with U.S. research institutions to develop an artificial intelligence-based radiopharmaceutical therapy platform aimed at exploring new treatment strategies for solid tumors that respond poorly to conventional therapies. The team is composed of professors including Myung Seung-jae from the Department of Gastroenterology, Oh Seung-jun from the Department of Nuclear Medicine, Ryu Chang-hoon from the Department of Oncology, Jung Byung-kwan from the Department of Pathology, and Son Byung-ho from the Department of Breast Surgery at Asan Medical Center. The project will combine Asan Medical Center's large-scale clinical and pathological data, Emory University's AI-based digital pathology analysis technology, and Case Western Reserve University and University Hospitals Cleveland Medical Center's pathological and clinical research capabilities.

2026-08-22